Up next

Autoplay

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Views • 07/17/23
Share
Embed
administrator
administrator
Subscribers
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay